Public launch for ICR, CR UK spinout Monte Rosa
The company aims to target cancer with new drugs that take advantage of protein degradation
Read More
Tag: Versant Ventures
UK’s Enterprise Therapeutics raises £29m
Brighton, UK-based Enterprise Therapeutics has raised £29 million to help it advance its experimental therapies for respiratory diseases.
Read More
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
